Skip to content

Ultrasound-Guided erector spinae plane block for postoperative analgesia in patients undergoing posterior cervical spine surgery: a randomized controlled trial

Ultrasound-Guided erector spinae plane block for postoperative analgesia in patients undergoing posterior cervical spine surgery: a randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070719
Enrollment
Unknown
Registered
2023-04-21
Start date
2023-04-21
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical spondylosis combined with spinal stenosis, spinal tumors, and cervical instability

Interventions

Sponsors

Department of Anesthesiology, West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) PCSS are indicated for patients with cervical spondylosis with posterior longitudinal ligament calcification, cervical spondylosis with spinal canal stenosis, cervical spondylosis with arachnoiditis, spinal canal tumor, and cervical instability; (2) Ages of 18-60 years with gender restriction; (3) The preoperative American Society of anesthesiologists (ASA) anesthesia risk assessment grade is I to II; (4) Patients who signed informed consent.

Exclusion criteria

Exclusion criteria: (1) Long-term opioid users (daily or nearly daily opioid use for > 3 months); (2) Alcohol or drug abuse or allergy to any of the drugs used in this study (local anesthetics, etc.); (3) Psychiatric patients, impaired speech and those unable to complete the visual analog scale (VAS) scale for pain; (4) Local skin infection, bleeding, etc., at the puncture site of anesthesia; (5) Abnormal coagulation (PT, APTT beyond normal, INR < = 1.4), platelet count < 80 × 109 / L), patients with likely abnormal platelet function; (6) Patients with spinal instability; (7) The surgical or anesthesiologist considered the patient unsuitable for inclusion;

Design outcomes

Primary

MeasureTime frame
Dosage of morphine within 24 h after surgery;

Secondary

MeasureTime frame
Intraoperative consumption of opioids;Postoperative Visual Analogue Scale Score;Times of sleep interruption due to pain on the night of surgery;Time until the first walkout of bed after surgery;Time to hospital discharge; The total cost of hospitalization;Total morphine consumption during hospitalization;postoperative adverse events;

Countries

China

Contacts

Public ContactYang Jing

West China Hospital, Sichuan University

422963362@qq.com+86 18980602269

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026